11-47343496-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM1PP3
The NM_000256.3(MYBPC3):c.1219G>A(p.Gly407Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000566 in 1,589,498 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G407R) has been classified as Uncertain significance.
Frequency
Consequence
NM_000256.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MYBPC3 | NM_000256.3 | c.1219G>A | p.Gly407Ser | missense_variant | 13/35 | ENST00000545968.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MYBPC3 | ENST00000545968.6 | c.1219G>A | p.Gly407Ser | missense_variant | 13/35 | 5 | NM_000256.3 | P4 | |
MYBPC3 | ENST00000399249.6 | c.1219G>A | p.Gly407Ser | missense_variant | 12/34 | 5 | A2 | ||
MYBPC3 | ENST00000544791.1 | c.1219G>A | p.Gly407Ser | missense_variant, NMD_transcript_variant | 13/27 | 5 |
Frequencies
GnomAD3 genomes ? AF: 0.0000131 AC: 2AN: 152114Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000487 AC: 7AN: 1437384Hom.: 0 Cov.: 51 AF XY: 0.00000421 AC XY: 3AN XY: 712586
GnomAD4 genome ? AF: 0.0000131 AC: 2AN: 152114Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74312
ClinVar
Submissions by phenotype
not specified Uncertain:2
Uncertain significance, no assertion criteria provided | clinical testing | Stanford Center for Inherited Cardiovascular Disease, Stanford University | Sep 01, 2014 | Note this variant was found in clinical genetic testing performed by one or more labs who may also submit to ClinVar. Thus any internal case data may overlap with the internal case data of other labs. The interpretation reviewed below is that of the Stanford Center for Inherited Cardiovascular Disease. p.Gly407Ser (c.1219 G>A) in MYBPC3 Based on the data reviewed below we consider this variant a variant of uncertain significance, likely disease causing. The variant has been seen in at least one unrelated cases of DCM with no segregation data. Waldmuller et al (2011) sequenced MYH7 and MYBPC3 in 652 patients with DCM from a multi-center German cohort and identified this variant in one patient. In silico analysis with PolyPhen-2 predicts the variant to be probably damaging. The glycine at codon 407 is completely conserved across species, as are neighboring amino acids. Other variants have been reported in association with disease at nearby codons (p.Ser408Asn, p.Gly416Ser). This substitution occurs 5 nucleotides from the end of exon 13, thus it is possible that the variant impacts splicing. I emailed GeneDx to ask what their in silico splicing prediction programs predict and they told me that the two algorithms they ran predict no impact on splicing. In total the variant has not been seen in ~6500 from publicly available population datasets. There is no variation at codon 407 listed in the NHLBI Exome Sequencing Project dataset, which currently includes variant calls on ~6500 Caucasian and African American individuals (as of March 8th, 2013). There is also no variation at this codon listed in dbSNP or 1000 genomes (as of March 8 th, 2013). - |
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | May 23, 2023 | Variant summary: MYBPC3 c.1219G>A (p.Gly407Ser) results in a non-conservative amino acid change located in the Immunoglobulin subtype 2 (IPR003598) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 210360 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.1219G>A has been reported in the literature in an individual affected with Dilated Cardiomyopathy (Waldmuller_2011). This report does not provide unequivocal conclusions about association of the variant with Cardiomyopathy. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 21750094). Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and all laboratories classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. - |
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 04, 2019 | The p.Gly407Ser variant in MYBPC3 has been reported in 1 German individual with DCM (Waldmuller 2011). It was absent from large population studies. Computational prediction tools and conservation analysis do not provide strong support for or against an impact to the protein. In summary, the clinical significance of the Gly407Ser variant is uncertain. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Dec 28, 2018 | - - |
Hypertrophic cardiomyopathy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Nov 22, 2023 | This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 407 of the MYBPC3 protein (p.Gly407Ser). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with dilated cardiomyopathy (PMID: 21750094). ClinVar contains an entry for this variant (Variation ID: 179988). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 07, 2021 | The p.G407S variant (also known as c.1219G>A), located in coding exon 13 of the MYBPC3 gene, results from a G to A substitution at nucleotide position 1219. The glycine at codon 407 is replaced by serine, an amino acid with similar properties. This variant has been detected in a dilated cardiomyopathy cohort; however, details were limited (Waldmüller S et al. Eur. J. Heart Fail., 2011 Nov;13:1185-92). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
MYBPC3-related disorder Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 08, 2023 | The MYBPC3 c.1219G>A variant is predicted to result in the amino acid substitution p.Gly407Ser. This variant was reported in one individual with dilated cardiomyopathy; however, further clinical details were not provided (Supplementary Table 2, Waldmüller et al 2011. PubMed ID: 21750094). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. Of note, other variants at the same amino acid (p.Gly407Arg and p.Gly407Asp) have been reported in patients with MYBPC3-related disease (Coban-Akdemir et al. 2020. PubMed ID: 32233023; Supplementary Table 1, Wang et al. 2014. PubMed ID: 25132132). Although we suspect that the c.1219G>A (p.Gly407Ser) variant could be pathogenic, at this time, we interpret its clinical significance as uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at